Expression/NN
of/IN
IkappaBalpha/NN
in/IN
the/DT
nucleus/NN
of/IN
human/JJ
peripheral/JJ
blood/NN
T/NN
lymphocytes/NNS
./.

According/VBG
to/TO
current/JJ
models/NNS
the/DT
inhibitory/JJ
capacity/NN
of/IN
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
would/MD
be/VB
mediated/VBN
through/IN
the/DT
retention/NN
of/IN
Rel/NF-kappaB/NN
proteins/NNS
in/IN
the/DT
cytosol/NN
./.
=====
However/RB
,/,
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
has/VBZ
also/RB
been/VBN
detected/VBN
in/IN
the/DT
nucleus/NN
of/IN
cell/NN
lines/NNS
and/CC
when/WRB
overexpressed/VBN
by/IN
transient/JJ
transfection/NN
./.
=====
To/TO
gain/VB
better/JJR
insight/NN
into/IN
the/DT
potential/JJ
role/NN
of/IN
nuclear/JJ
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
in/IN
a/DT
physiological/JJ
context/NN
we/PRP
have/VBP
analysed/VBN
its/PRP$
presence/NN
in/IN
the/DT
nucleus/NN
of/IN
human/JJ
peripheral/JJ
blood/NN
T/NN
lymphocytes/NNS
(/(
PBL/NN
)/)
./.
=====
We/PRP
demonstrate/VBP
the/DT
nuclear/JJ
localization/NN
of/IN
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
in/IN
PBL/NN
by/IN
different/JJ
techniques/NNS
:/:
Western/NN
blot/NN
,/,
indirect/JJ
immunofluorescence/NN
and/CC
electron/NN
microscopy/NN
./.
=====
Low/JJ
levels/NNS
of/IN
nuclear/JJ
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
were/VBD
detected/VBN
in/IN
resting/VBG
cells/NNS
whereas/IN
a/DT
superinduction/NN
was/VBD
obtained/VBN
after/IN
PMA/NN
activation/NN
./.
=====
The/DT
nuclear/JJ
pool/NN
of/IN
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
showed/VBD
a/DT
higher/JJR
stability/NN
than/IN
cytosolic/JJ
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
and/CC
was/VBD
partially/RB
independent/JJ
of/IN
the/DT
resynthesis/NN
of/IN
the/DT
protein/NN
./.
=====
Unexpectedly/RB
,/,
the/DT
presence/NN
of/IN
nuclear/JJ
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
did/VBD
not/RB
inhibit/VB
NF-kappaB/NN
binding/NN
to/TO
DNA/NN
and/CC
this/DT
phenomenon/NN
was/VBD
not/RB
due/JJ
to/TO
the/DT
presence/NN
of/IN
IkappaBbeta/NN
at/IN
the/DT
nuclear/JJ
level/NN
./.
=====
Immunoprecipitation/NN
experiments/NNS
failed/VBD
to/TO
demonstrate/VB
an/DT
association/NN
between/IN
nuclear/JJ
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
and/CC
NF-kappaB/NN
proteins/NNS
./.
=====
Our/PRP$
results/NNS
demonstrate/VBP
that/IN
in/IN
resting/VBG
and/CC
PMA-activated/JJ
human/JJ
PBL/NN
,/,
I/NN
(/(
kappa/NN
)/)
B/NN
(/(
alpha/NN
)/)
is/VBZ
present/JJ
in/IN
the/DT
nucleus/NN
in/IN
an/DT
apparently/RB
inactive/JJ
form/NN
unable/JJ
to/TO
disrupt/VB
NF-kappaB/NN
binding/NN
from/IN
DNA/NN
./.